Xeris Submits Glucagon Rescue Pen to FDA: A Dramatically Easier and Faster Treatment for Severe Hypoglycemia | diaTribe
Biodel, Latitude, and Xeris Seek to Improve Glucagon | diaTribe
A Demand for Better Glucagon Products and Policy
Xeris Pharmaceuticals Submits New Drug Application for Glucagon Rescue Pen | dLife
Xeris Pharmaceuticals Receives European Commission Approval of Ogluo™ ( glucagon) Injection for the Treatment of Severe Hypoglycaemia in Adults, Adolescents, and Children Aged 2 Years and Over With Diabetes Mellitus | Business Wire
Zegalogue: A New Easy-to-Use Diabetes Rescue Glucagon
Xeris' severe low blood sugar pen gets FDA approval -
FDA Approves Potentially Life Saving GVOKE: Xeris' Ready-to-Use Glucagon | diaTribe
Xeris gets $41M for shelf-stable glucagon pen
Xeris Pharmaceuticals Aims For $75 Million IPO (NASDAQ:XERS) | Seeking Alpha
Xeris: Looking For Entry Before PDUFA (NASDAQ:XERS) | Seeking Alpha
Next-Gen Emergency Glucagon: Xeris to the Rescue? | Type one diabetes, Diabetes supplies, Diabetes
xeriscanaccordaug2018fin
Next-Gen Emergency Glucagon: Xeris to the Rescue? | Diabetes technology, Diabetes diet plan, Diabetes management
Xeris: Looking For Entry Before PDUFA (NASDAQ:XERS) | Seeking Alpha
Xeris | diaTribe
Xeris scores first FDA nod with shelf-stable glucagon injector, syringe | FiercePharma
Xeris: Preparing For The Gvoke PDUFA (NASDAQ:XERS) | Seeking Alpha
Xeris Pharmaceuticals Announces FDA Acceptance for Review of NDA for Its Ready-to-Use Glucagon Rescue Pen | Business Wire
Ready-To-Use Glucagon Rescue Pen
New Glucagon Rescue Pen: Gvoke HypoPen - Diabetes Self-Management
Coming Soon: Generic Glucagon Rescue
Xeris Raises $55M for Glucagon Rescue Pen | BioSpace
In the Know with GVOKE: Conversations about Severe Low Blood Sugar and New Treatment Options – Greater New York City Chapter
Glucagon Rescue Meds and PocketCard - Diabetes Education Services
Xeris Pharma Announces FDA to Review NDA for Its Ready-to-Use Glucagon Rescue Pen | dLife
